.STUDY EMPHASIZE.19 September 2024. Plozasiran decreased triglyceride levels through 80% and decreased the threat of pancreatitis in clients along with relentless chylomicronemia, along with or without a hereditary medical diagnosis.
A hub for all-inclusive insights on global news, finance, technology, health, and lifestyle.
.STUDY EMPHASIZE.19 September 2024. Plozasiran decreased triglyceride levels through 80% and decreased the threat of pancreatitis in clients along with relentless chylomicronemia, along with or without a hereditary medical diagnosis.